ALEC Insider Transactions — Page 2
329 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–200; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Rosenthal Arnon | Chief Executive Officer | 2021-11-04 | Sale | 15,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-04 | Sale | 15,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-04 | Sale | 55,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-09-23 | Sale | 9,625.0 | $25.1 |
| Rosenthal Arnon | Chief Executive Officer | 2021-09-22 | Sale | 5,283.0 | $26.1 |
| Rosenthal Arnon | Chief Executive Officer | 2021-09-22 | Sale | 94,717.0 | $25.29 |
| Rosenthal Arnon | Chief Executive Officer | 2021-09-21 | Sale | 8,462.0 | $26.56 |
| Rosenthal Arnon | Chief Executive Officer | 2021-09-21 | Sale | 91,538.0 | $26.07 |
| Rosenthal Arnon | Chief Executive Officer | 2021-09-20 | Sale | 8,046.0 | $26.33 |
| Rosenthal Arnon | Chief Executive Officer | 2021-09-20 | Sale | 91,954.0 | $25.76 |
| Paul Robert | Chief Medical Officer | 2021-08-09 | Sale | 300.0 | $27.79 |
| Paul Robert | Chief Medical Officer | 2021-08-09 | Sale | 22,650.0 | $27.17 |
| SCHELLER RICHARD H | Director | 2021-08-05 | Sale | 3,392.0 | $28.3 |
| SCHELLER RICHARD H | Director | 2021-08-05 | Sale | 52,868.0 | $27.64 |
| Paul Robert | Chief Medical Officer | 2021-07-07 | Sale | 17,149.0 | $39.32 |
| Paul Robert | Chief Medical Officer | 2021-07-07 | Sale | 7,700.0 | $38.14 |
| Paul Robert | Chief Medical Officer | 2021-07-07 | Sale | 4,900.0 | $37.41 |
| Paul Robert | Chief Medical Officer | 2021-07-06 | Sale | 1,100.0 | $40.01 |
| Paul Robert | Chief Medical Officer | 2021-07-06 | Sale | 10,495.0 | $39.2 |
| Paul Robert | Chief Medical Officer | 2021-07-06 | Sale | 3,581.0 | $38.55 |
| Paul Robert | Chief Medical Officer | 2021-07-06 | Sale | 1,000.0 | $37.43 |
| Paul Robert | Chief Medical Officer | 2021-07-06 | Sale | 3,600.0 | $35.95 |
| Paul Robert | Chief Medical Officer | 2021-07-06 | Sale | 10,224.0 | $35.1 |
| Yu Calvin | Vice President, Finance | 2021-07-06 | Sale | 3,334.0 | $34.65 |
| SCHELLER RICHARD H | Director | 2021-07-02 | Sale | 9,981.0 | $31.14 |
| Yu Calvin | Vice President, Finance | 2021-07-02 | Sale | 20,000.0 | $40.02 |
| Yu Calvin | Vice President, Finance | 2021-07-02 | Sale | 90,840.0 | $31.14 |
| King Robert | Chief Development Officer | 2021-07-02 | Sale | 60,000.0 | $31.14 |
| Paul Robert | Chief Medical Officer | 2021-07-02 | Sale | 30,000.0 | $31.14 |
| Paul Robert | Chief Medical Officer | 2021-07-01 | Sale | 26,726.0 | $22.23 |
| Paul Robert | Chief Medical Officer | 2021-06-16 | Sale | 4,600.0 | $22.18 |
| Paul Robert | Chief Medical Officer | 2021-06-15 | Sale | 30,000.0 | $22.07 |
| Paul Robert | Chief Medical Officer | 2021-06-08 | Sale | 800.0 | $20.83 |
| Paul Robert | Chief Medical Officer | 2021-06-08 | Sale | 2,200.0 | $19.89 |
| Paul Robert | Chief Medical Officer | 2021-06-08 | Sale | 16,175.0 | $19.0 |
| Yu Calvin | Vice President, Finance | 2021-06-02 | Sale | 1,844.0 | $17.77 |
| Paul Robert | Chief Medical Officer | 2021-05-21 | Sale | 14,975.0 | $18.14 |
| Paul Robert | Chief Medical Officer | 2021-05-18 | Sale | 4,200.0 | $18.04 |
| Paul Robert | Chief Medical Officer | 2021-04-07 | Sale | 45.0 | $19.83 |
| Paul Robert | Chief Medical Officer | 2021-04-07 | Sale | 22,255.0 | $19.19 |
| Paul Robert | Chief Medical Officer | 2021-03-23 | Sale | 13,800.0 | $22.21 |
| Paul Robert | Chief Medical Officer | 2021-03-22 | Sale | 5,510.0 | $23.55 |
| Paul Robert | Chief Medical Officer | 2021-03-22 | Sale | 24,490.0 | $22.85 |
| Paul Robert | Chief Medical Officer | 2021-03-09 | Sale | 19,175.0 | $18.12 |
| Paul Robert | Chief Medical Officer | 2021-02-09 | Sale | 19,175.0 | $20.81 |
| Paul Robert | Chief Medical Officer | 2021-01-26 | Sale | 27,308.0 | $18.0 |
| Paul Robert | Chief Medical Officer | 2021-01-25 | Sale | 30,000.0 | $18.01 |
| Paul Robert | Chief Medical Officer | 2021-01-20 | Sale | 8,567.0 | $18.0 |
| Paul Robert | Chief Medical Officer | 2021-01-19 | Sale | 30,000.0 | $18.12 |
| Paul Robert | Chief Medical Officer | 2020-07-15 | Sale | 378.0 | $23.58 |
| Paul Robert | Chief Medical Officer | 2020-07-15 | Sale | 9,622.0 | $22.94 |
| MCGUIRE TERRANCE | Director,TenPercentOwner | 2020-06-23 | Sale | 4,377.0 | $31.54 |
| Polaris Venture Partners VI, L.P. | TenPercentOwner | 2020-06-23 | Sale | 4,377.0 | $31.54 |
| Polaris Venture Partners Founders' Fund VI, L.P. | TenPercentOwner | 2020-06-23 | Sale | 4,377.0 | $31.54 |
| Polaris Venture Management Co. VI, L.L.C. | TenPercentOwner | 2020-06-23 | Sale | 4,377.0 | $31.54 |
| Polaris Venture Partners VI (AIV), L.P. | TenPercentOwner | 2020-06-23 | Sale | 4,377.0 | $31.54 |
| PVP VI (AIV) Feeder Corp. Holding Partnership, L.P. | TenPercentOwner | 2020-06-23 | Sale | 4,377.0 | $31.54 |
| Paul Robert | Chief Medical Officer | 2020-06-15 | Sale | 3,909.0 | $29.9 |
| Paul Robert | Chief Medical Officer | 2020-06-15 | Sale | 6,091.0 | $29.43 |
| Yu Calvin | Vice President, Finance | 2020-06-03 | Sale | 300.0 | $32.02 |
| Yu Calvin | Vice President, Finance | 2020-06-03 | Sale | 1,043.0 | $31.04 |
| Paul Robert | Chief Medical Officer | 2020-05-15 | Sale | 2,104.0 | $27.78 |
| Paul Robert | Chief Medical Officer | 2020-05-15 | Sale | 5,996.0 | $27.0 |
| Paul Robert | Chief Medical Officer | 2020-05-15 | Sale | 1,900.0 | $26.15 |
| King Robert | Chief Development Officer | 2020-05-15 | Sale | 3,003.0 | $27.78 |
| King Robert | Chief Development Officer | 2020-05-15 | Sale | 8,632.0 | $27.02 |
| King Robert | Chief Development Officer | 2020-05-15 | Sale | 3,365.0 | $26.24 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-04-16 | Sale | 15,086.0 | $23.53 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-04-16 | Sale | 15,086.0 | $23.53 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-04-16 | Sale | 47,097.0 | $23.53 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-04-16 | Sale | 47,097.0 | $23.53 |
| Paul Robert | Chief Medical Officer | 2020-04-15 | Sale | 10,000.0 | $22.27 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-04-14 | Sale | 5,636.0 | $23.52 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-04-14 | Sale | 5,636.0 | $23.52 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-04-14 | Sale | 17,595.0 | $23.52 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-04-14 | Sale | 17,595.0 | $23.52 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-04-09 | Sale | 69,893.0 | $23.79 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-04-09 | Sale | 69,893.0 | $23.79 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-04-09 | Sale | 218,208.0 | $23.79 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-04-09 | Sale | 218,208.0 | $23.79 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-04-08 | Sale | 20,041.0 | $23.65 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-04-08 | Sale | 20,041.0 | $23.65 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-04-08 | Sale | 62,573.0 | $23.65 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-04-08 | Sale | 62,573.0 | $23.65 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-04-07 | Sale | 2,224.0 | $23.1 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-04-07 | Sale | 2,224.0 | $23.1 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-04-07 | Sale | 6,946.0 | $23.1 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-04-07 | Sale | 6,946.0 | $23.1 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-03-31 | Sale | 60,645.0 | $24.5 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-03-31 | Sale | 60,645.0 | $24.5 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-03-31 | Sale | 189,355.0 | $24.5 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-03-31 | Sale | 189,355.0 | $24.5 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-03-25 | Sale | 13,684.0 | $24.66 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-03-25 | Sale | 13,684.0 | $24.66 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-03-25 | Sale | 42,727.0 | $24.66 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-03-25 | Sale | 42,727.0 | $24.66 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-03-24 | Sale | 16,409.0 | $24.45 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-03-24 | Sale | 16,409.0 | $24.45 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-03-24 | Sale | 51,235.0 | $24.45 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-03-24 | Sale | 51,235.0 | $24.45 |